Related Experiment Video
Updated: Jul 20, 2026
10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Approaches to improved influenza vaccination.
1University of Rochester, Rochester, New York, USA.
Vaccine
|February 26, 2000
Summary
Inactivated influenza vaccine (Ivac) is less effective in the elderly. Combining Ivac with live attenuated influenza vaccine (Livac) reduces infection rates in high-risk elderly individuals.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Inactivated influenza vaccine (Ivac) reduces influenza attack rates and illness severity.
- Ivac efficacy is reduced in the elderly due to lower response rates and antibody titers.
- Elderly individuals are prone to complications from influenza, even with vaccination.
Purpose of the Study:
- To evaluate strategies for improving influenza vaccine effectiveness in the elderly.
- To investigate the impact of combining Ivac with live attenuated influenza vaccine (Livac).
- To explore alternative vaccine formulations like baculovirus recombinant or adjuvanted Ivac.
Main Methods:
- Clinical trials comparing Ivac alone versus combined Ivac and Livac in elderly populations.
- Assessment of infection rates, illness severity, and antibody responses.
- Investigation of novel vaccine platforms (baculovirus recombinant, adjuvanted Ivac) for enhanced mucosal immunity.
Main Results:
- Simultaneous administration of Livac and Ivac reduced infection and illness rates in high-risk elderly individuals.
- Livac's ability to stimulate secretory antibodies at mucosal surfaces is presumed to be key.
- Ongoing research into recombinant and adjuvanted vaccines aims for improved mucosal neutralization.
Conclusions:
- Combining inactivated and live attenuated influenza vaccines offers a promising strategy for enhancing protection in the elderly.
- Stimulating mucosal immunity is crucial for preventing influenza infection in at-risk populations.
- Further research into novel vaccine technologies is warranted to improve elderly influenza vaccine efficacy.
Related Concept Videos
01:51Vaccinations
Overview
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...